Kevin E. Weddington

Array ( [id] => 9059444 [patent_doc_number] => 08545879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Fast disintegrating compositions of meloxicam' [patent_app_type] => utility [patent_app_number] => 12/988919 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6765 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371262 [patent_doc_number] => 20120220651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'DESFERRIOXAMINE-METAL COMPLEXES FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/390838 [patent_app_country] => US [patent_app_date] => 2010-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 37401 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6008009 [patent_doc_number] => 20110060040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'USES OF ACYLOXYALKYL CARBAMATE PRODRUGS OF TRANEXAMIC ACID' [patent_app_type] => utility [patent_app_number] => 12/858401 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13753 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060040.pdf [firstpage_image] =>[orig_patent_app_number] => 12858401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039481 [patent_doc_number] => 20110092530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Cyclopamine tartrate salt and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/806271 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5480 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092530.pdf [firstpage_image] =>[orig_patent_app_number] => 12806271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6263449 [patent_doc_number] => 20100297263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'COLON CLEANSING COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/852473 [patent_app_country] => US [patent_app_date] => 2010-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16447 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297263.pdf [firstpage_image] =>[orig_patent_app_number] => 12852473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978316 [patent_doc_number] => 20110071219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'Hemostatic Effects of Glucono-Delta-Lactone' [patent_app_type] => utility [patent_app_number] => 12/851041 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8230 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071219.pdf [firstpage_image] =>[orig_patent_app_number] => 12851041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221791 [patent_doc_number] => 20120135995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'FUNGICIDAL DIPHENYL-SUBSTITUTED PYRIDAZINES' [patent_app_type] => utility [patent_app_number] => 13/389265 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27085 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757000 [patent_doc_number] => 20120029001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'METHOD OF TREATMENT OF NEPHROGENIC DIABETES INSIPIDUS' [patent_app_type] => utility [patent_app_number] => 12/847553 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1858 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029001.pdf [firstpage_image] =>[orig_patent_app_number] => 12847553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352646 [patent_doc_number] => 20100331382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'PROCESSES OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/840505 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5686 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331382.pdf [firstpage_image] =>[orig_patent_app_number] => 12840505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302045 [patent_doc_number] => 20120184604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'COMPOSITION FOR THE PREVENTION OR TREATMENT OF BONE DISEASES COMPRISING COLFORSIN DAROPATE' [patent_app_type] => utility [patent_app_number] => 13/384560 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4405 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8375394 [patent_doc_number] => 08258186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Pharmaceutical for oral delivery comprising MGBG' [patent_app_type] => utility [patent_app_number] => 12/837753 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38299 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12837753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433598 [patent_doc_number] => 20100278804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders' [patent_app_type] => utility [patent_app_number] => 12/837067 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13311 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278804.pdf [firstpage_image] =>[orig_patent_app_number] => 12837067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9299852 [patent_doc_number] => 08648080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility' [patent_app_type] => utility [patent_app_number] => 13/383056 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10836 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097715 [patent_doc_number] => 20110003803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/829973 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5125 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003803.pdf [firstpage_image] =>[orig_patent_app_number] => 12829973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313657 [patent_doc_number] => 20120190690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'ELTOPRAZINE FOR THE TREATMENT OF WEIGHT DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/381203 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6895 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10876322 [patent_doc_number] => 08901109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-02 [patent_title] => 'Quercetin-containing compositions' [patent_app_type] => utility [patent_app_number] => 12/821287 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2701 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12821287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574858 [patent_doc_number] => 20100273703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Co-Therapy For Diabetic Conditions' [patent_app_type] => utility [patent_app_number] => 12/816653 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6499 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273703.pdf [firstpage_image] =>[orig_patent_app_number] => 12816653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538338 [patent_doc_number] => 08314059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Diabetic nephropathy therapies' [patent_app_type] => utility [patent_app_number] => 12/802373 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14992 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12802373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817397 [patent_doc_number] => 20120064017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'BORINIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/319802 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11178 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064017.pdf [firstpage_image] =>[orig_patent_app_number] => 13319802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212411 [patent_doc_number] => 20110135711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Methods and Compositions for Delivery of Catecholic Butanes for Treatment of Tumors' [patent_app_type] => utility [patent_app_number] => 12/790894 [patent_app_country] => US [patent_app_date] => 2010-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26018 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135711.pdf [firstpage_image] =>[orig_patent_app_number] => 12790894 [rel_patent_id] =>[rel_patent_doc_number] =>)